Nathalie Levin Cohen
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Nathalie Levin Cohen has a total of 10 co-authors. Here are the top co-authors by number of shared publications:
- Ariela Aline Souroujon Torun
Center for Research in Health Sciences (CICSA), Faculty of Health Sciences Anahuac University, Mexico City, Mexico
2 shared publications - Andrea Arnábar Newpher1 shared publication
- Cesar Alejandro Reyes Salcedo
Dermatology Clinic Dermacares Mexico City Mexico
1 shared publication - Esteban González Palomo1 shared publication
- Galia Capuano
Universidad Anahauc México Huixquilucan Mexico
1 shared publication - Gerardo Sanfelíz Sepúlveda1 shared publication
Latest Publications
- 15 September 2023
- Published by Wiley in International Journal of Dermatology
- Vol. 62 (11) , 1324-1331
Autologous cell transplant as a treatment for stable segmental vitiligo: a systematic review
Objective: This systematic review provides a comprehensive analysis of the efficacy of autologous cell transplant as a therapeutic approach for stable segmental vitiligo. Vitiligo poses significant challenges for healthcare professionals in terms of treatment selection. Autologous cell transplant has emerged as a promising modality for managing vitiligo, with cultured and noncultured transplants being considered when determining the patient's treatment approach. There is little knowledge and literature on the subject, so we analyze the different studies.Method: Using online medical literature databases and the PRISMA guidelines, six out of 60 articles met the acceptance criteria to be analyzed, emphasizing the lack of current literature on this subject.Results: Autologous cell transplant achieves excellent pigmentation rates for many body parts. We found that cultivated cells had better results than noncultivated ones. Both types of treatments could pigment 80% or more where needed.Conclusion: This review highlights the importance of autologous cell transplant as a new and reliable tool for the treatment of stable segmental vitiligo, cultured transplants being the most effective. By employing autologous cell transplant, the repigmentation rate is notably high and consistently achievable. Although its cost and logistical complexities hinder the current accessibility to this therapy, efforts are being made to enhance its availability, and its scope is expected to expand further. More studies are needed to understand this therapy method in other kinds of vitiligo.
- 15 September 2023
- Published by Wiley in International Journal of Dermatology
- Vol. 62 (11) , 1324-1331
Autologous cell transplant as a treatment for stable segmental vitiligo: a systematic review
Objective: This systematic review provides a comprehensive analysis of the efficacy of autologous cell transplant as a therapeutic approach for stable segmental vitiligo. Vitiligo poses significant challenges for healthcare professionals in terms of treatment selection. Autologous cell transplant has emerged as a promising modality for managing vitiligo, with cultured and noncultured transplants being considered when determining the patient's treatment approach. There is little knowledge and literature on the subject, so we analyze the different studies.Method: Using online medical literature databases and the PRISMA guidelines, six out of 60 articles met the acceptance criteria to be analyzed, emphasizing the lack of current literature on this subject.Results: Autologous cell transplant achieves excellent pigmentation rates for many body parts. We found that cultivated cells had better results than noncultivated ones. Both types of treatments could pigment 80% or more where needed.Conclusion: This review highlights the importance of autologous cell transplant as a new and reliable tool for the treatment of stable segmental vitiligo, cultured transplants being the most effective. By employing autologous cell transplant, the repigmentation rate is notably high and consistently achievable. Although its cost and logistical complexities hinder the current accessibility to this therapy, efforts are being made to enhance its availability, and its scope is expected to expand further. More studies are needed to understand this therapy method in other kinds of vitiligo.
- Open Access
- 1 April 2023
- Published by Turkish Society of Clinical Enteral and Parenteral Nutrition in Clinical Science of Nutrition
- Vol. 5 (1) , 37-40
Nutritional Bicytopenia in the Context of a Very Low-Calorie Diet with Adequate Micronutrient Supplementation
The aim of this study is to establish the ideal clinician's approach to nutritional bicytopenia in the context of adequate micronutrient supplementation. We present the case of a 27-year-old patient living with obesity, subjected for months to a very low-calorie diet and adequate supplementation with complementary vitamins and minerals, evaluated and treated for bicytopenia with irondeficiency anemia and lymphocytopenia. The use of meal replacement supplements as nutritional sources replacing food items requires medical supervision as they can have consequences on the patient's micronutrient balance. Classically, and frequently, iron-deficiency anemias have been identified as the most common condition in these restrictive nutritional regimens. However, alterations in the white cell line are more frequent than believed and may be associated with multiple nutritional deficiencies including folic acid and vitamin B12. The diagnostic approach becomes complex when the most common nutritional causes are hidden by replacement supplements. The patient achieved an increase in hemoglobin after treatment (12.3 g/dL), recovering from anemia. When approaching nutritional cytopenias, the primary takeaway should always be the thinking process. Every patient with bicytopenia must be studied particularly meticulously, and the good clinician is forced to address it and reach the most likely diagnosis within the common and the rare.
- 1 April 2023
- Published by Turkish Society of Clinical Enteral and Parenteral Nutrition in Clinical Science of Nutrition
- Vol. 5 (1) , 37-40
Open AccessNutritional Bicytopenia in the Context of a Very Low-Calorie Diet with Adequate Micronutrient Supplementation
The aim of this study is to establish the ideal clinician's approach to nutritional bicytopenia in the context of adequate micronutrient supplementation. We present the case of a 27-year-old patient living with obesity, subjected for months to a very low-calorie diet and adequate supplementation with complementary vitamins and minerals, evaluated and treated for bicytopenia with irondeficiency anemia and lymphocytopenia. The use of meal replacement supplements as nutritional sources replacing food items requires medical supervision as they can have consequences on the patient's micronutrient balance. Classically, and frequently, iron-deficiency anemias have been identified as the most common condition in these restrictive nutritional regimens. However, alterations in the white cell line are more frequent than believed and may be associated with multiple nutritional deficiencies including folic acid and vitamin B12. The diagnostic approach becomes complex when the most common nutritional causes are hidden by replacement supplements. The patient achieved an increase in hemoglobin after treatment (12.3 g/dL), recovering from anemia. When approaching nutritional cytopenias, the primary takeaway should always be the thinking process. Every patient with bicytopenia must be studied particularly meticulously, and the good clinician is forced to address it and reach the most likely diagnosis within the common and the rare.